| 1 |
34512362 | Influence of FMO3 and CYP3A4 Polymorphisms on the Pharmacokinetics of Teneligliptin in Humans. | 2021 |
3 |
| 2 |
30982160 | The Unique Pharmacological and Pharmacokinetic Profile of Teneligliptin: Implications for Clinical Practice. | 2019 May |
1 |
| 3 |
31094010 | Effect of glimepiride on the pharmacokinetics of teneligliptin in healthy Korean subjects. | 2019 Oct |
1 |
| 4 |
23855261 | Metabolism and disposition of the dipeptidyl peptidase IV inhibitor teneligliptin in humans. | 2014 Mar |
1 |
| 5 |
24726088 | Effect of ketoconazole on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor teneligliptin: an open-label study in healthy white subjects in Germany. | 2014 May |
2 |